High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes

Journal of Surgical Oncology

Volumn 102, Issue 1, 2010, Pages 11-17

  Takashi, Ibe ^a   Shimizu, Kimihiro ^a   Nakano, Tetsuhiro ^a   Kakegawa, Seiichi ^a   Kamiyoshihara, Mitsuhiro ^a   Nakajima, Takashi ^a   Kaira, Kyoichi ^a   Takeyoshi, Izumi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

High grade neuroendocrine carcinoma of the lung; Large cell neuroendocrine carcinoma; Small cell lung carcinoma; Thymidylate synthase

Indexed keywords

MESSENGER RNA; THYMIDYLATE SYNTHASE;

ARTICLE; CANCER CELL CULTURE; CANCER GRADING; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LASER CAPTURE MICRODISSECTION; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMALL CELL LUNG CARCINOMA; THYMIDYLATE SYNTHASE;

EID: 77954117079     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21576     Document Type: Article

References (27)

1. World Health Organization: Histological typing of lung and pleural tumours, 3rd edition. Berlin, Heidelberg, Germany: Springer-Verlag; 1999.
2. Travis WD, Linnoila RI, Tsokos MG, et al.: Neuroendocrinetumors of the lung with proposed criteria for large-cell neuro-endocrine carcinoma: An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991;15:529-553.
3. Cooper WA, Thourani VH, Gal AA, et al.: The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest 2001;119:14-18.
4. Gracia-Yuste M, Matilla JM, Alvarez-Gago T, et al.: A Spanish multicenter study. Ann Thorac Surg 2000;70:258-263.
5. Travis WD, Rush W, Fielder DB, et al.: Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation form typical carcinoid. Am J Surg Pathol 1998;22:934-944. (Pubitemid 28364493)
6. Dresler CM, Ritter JH, Patterson GA, et al.: Clinical-pathological analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 1997;63:180-185. (Pubitemid 27039058)
7. El Maalouf G, Rodier JM, Faivre S, et al.: Could we expect to improve survival in small cell lung cancer? Lung Cancer 2007;57:S30-S34.
8. Jiang SX, Kameya T, Shoji M: Large cell neuroendocrine carcinoma of the lung: A histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 1998;22:526-537. (Pubitemid 28213738)
9. Takei H, Asamura H, Maeshima A: Large cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 2002;124:285-292. (Pubitemid 35025604)
10. Asamura H, Kameya T, Matsuno Y: Neuroendocrine neoplasm of the lung: A prognostic spectrum. J Clin Oncol 2006;24:70-76.
11. Danenberg PV: Thymidylate synthase: A target enzyme in cancer chemotherapy. Biochem Biophys Acta 1977;473:73-92.
12. Johnston PG, Lenz HJ, Leichman CG: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumor. Cancer Res 1995;55:1407-1412.
13. Lenz H, Leichman CG, Danenberg KD, et al.: Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival. J Clin Oncol 1995;14:176-182.
14. Nishimura R, Nagao K, Miyayama H, et al.: Thymidylate synthase levels as a therapeutic and prognostic predictor in breast cancer. Anticancer Res 1999;19:5621-5626.
15. Shirota Y, Stoehlmacher J, Brabender J, et al.: ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J Clin Oncol 2001;19:4298-4304. (Pubitemid 33096777)
16. Shiga H, Heath EI, Rasmussen AA, et al.: Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res 1995;5:4097-4104. (Pubitemid 30013791)
17. Shintani Y, Ohta M, Hirabayashi H, et al.: Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small cell lung carcinoma. Lung Cancer 2004;45:189-196. (Pubitemid 38891481)
18. Emmert-Buck MR, Bonner RF, Smith PD, et al.: Laser capture microdissection. Science 1996;274:998-1001.
19. Lord RV, Salonga D, Danenberg KD, et al.: Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, adenocarcinoma sequence. J Gastrointest Surg 2000;4:135-142.
20. Kornmann M, Schwada W, Sader S, et al.: Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: Predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clin Cancer Res 2003;9:4116-4124.
21. Gibson UE, Heid CA,Williams PM: A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001. (Pubitemid 26388092)
22. Heid CA, Stevens J, Livak KJ, et al.: Real time quantitative PCR. Genome Res 1996;6:986-994.
23. Okabe H, Tsujimoto H, Fukushima M: Preparation of the antibodies against recombinant human thymidylate synthase for detection of its intratumoral levels and the application to sensitivity-study of 5-fluorouracil. Oncol Rep 1997;4:685-690. (Pubitemid 27286971)
24. McCarty KS, Jr., Szabo E, Flowers JL, et al.: Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 1986;46:4244s-4248s.
25. Ceppi P, Volante M, Saviozzi S, et al.: Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase. Cancer 2006;107:1589-1596.
26. Ichikawa W, Takahashi T, Suto K, et al.: Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer. Int J Cancer 2004;112:967-973.
27. Oguri T, Achiwa H, Bessho Y, et al.: The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. Lung Cancer 2005;49:345-351. (Pubitemid 41139147)